Precision medicine focused on immune-mediated neuropsychiatric, cardiovascular, long-COVID, and neurodegenerative disorders
Moleculera Biosciences, Inc. has raised $500K in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Moleculera Biosciences, Inc.'s investors include i2i, i2E, Oklahoma Center for the Advancement of Science and Technology, Oklahoma Seed Capital Fund, SeedStep Angels.
Moleculera Biosciences, Inc. is headquartered in Oklahoma City, United States.
Precision medicine focused on immune-mediated neuropsychiatric, cardiovascular, long-COVID, and neurodegenerative disorders
Moleculera Biosciences, Inc. is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moleculera Biosciences, Inc. — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/moleculera-biosciences-inc. Accessed September 30, 2026.
VCBacked. (2024). Moleculera Biosciences, Inc. — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/moleculera-biosciences-inc
{{cite web |title=Moleculera Biosciences, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/moleculera-biosciences-inc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated